Pharma Focus Asia

Eisai, Gates Ventures, HDR UK, LifeArc and The University of Edinburgh Announce New NEURii Research Collaboration

Thursday, June 29, 2023

Eisai, Gates Ventures, Health Data Research UK (HDR UK), LifeArc, and The University of Edinburgh have made an announcement regarding a new collaborative research agreement.  

The collaboration, named NEURii, is a pioneering initiative that harnesses the power of collaboration across various domains, including therapeutics, technology development and commercialisation, health data management, and advanced analytics/data science. By combining these different areas of expertise, NEURii intends to predict, protect, and promote brain health through the development of data and digital solutions.

This collaborative research agreement is a significant step to improve the diagnosis of dementia and develop effective solutions for individuals at risk of developing the disease.

The NEURii collaboration aims to leverage the expertise and capabilities of its partners to create an exciting platform for the development of transformative digital products. By combining their unique perspectives and knowledge, the collaborators aspire to address the persistent challenges associated with dementia and neurodegenerative conditions. NEURii enhances the existing treatment options for patients and address the challenges related to the prediction, prevention, management, and treatment of dementia-related disorders.

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference